Karyopharm Therapeutics Inc.
NasdaqGS:KPTI
$ 1.15
$0.00 (0.00%)
$ 1.15
$0.00 (0.00%)
End-of-day quote: 05/17/2024

KPTI - Karyopharm Therapeutics Stock Prediction 2025 - 2030

11 years of reliable Karyopharm Therapeutics stock forecast. The Wall Street analysts predict Outperform for KPTI. See at a glance whether NasdaqGS:KPTI will rise in the future.

$0.00
Forecast 2023
$1.37 $1.52
Forecast 2025
$2.58 $2.87
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$1.37 $1.52
Forecast 2030
$2.58 $2.87
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.15
Price-to-book Ratio
N/A
Market Cap
0.12B
TEV
0.27 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$6.00

Karyopharm Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Karyopharm Therapeutics Stock Forecast 2023

$5.00

In the last five quarters, Karyopharm Therapeutics’s Price Target has fallen from $11.12 to $6.00 - a -46.04% decrease. Six analysts predict that Karyopharm Therapeutics’s share price will fall in the coming year, reaching $5.00. This would represent a decrease of -16.67%.

334.78%
334.78
Last update: 05/20/2024

Highest Price Target $8.00

Average Price Target $5.00

Lowest Price Target $2.00

Karyopharm Therapeutics Stock Predictions 2025

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Jan 2025.

In January 2025, analysts believe the stock price will be $1.25. An increase of 8.99% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Feb 2025.

In February 2025, analysts believe the stock price will be $1.28. An increase of 11.09% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Mar 2025.

In March 2025, analysts believe the stock price will be $1.30. An increase of 13.2% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Apr 2025.

In April 2025, analysts believe the stock price will be $1.33. An increase of 15.3% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in May 2025.

In May 2025, analysts believe the stock price will be $1.35. An increase of 17.4% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Jun 2025.

In June 2025, analysts believe the stock price will be $1.37. An increase of 19.51% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Jul 2025.

In July 2025, analysts believe the stock price will be $1.40. An increase of 21.61% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Aug 2025.

In August 2025, analysts believe the stock price will be $1.42. An increase of 23.72% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Sep 2025.

In September 2025, analysts believe the stock price will be $1.45. An increase of 25.82% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Oct 2025.

In October 2025, analysts believe the stock price will be $1.47. An increase of 27.93% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Nov 2025.

In November 2025, analysts believe the stock price will be $1.50. An increase of 30.03% compared to the previous month's estimate.

Stock Forecast for the Price of an Karyopharm Therapeutics Share in Dec 2025.

In December 2025, analysts believe the stock price will be $1.52. An increase of 32.14% compared to the previous month's estimate.

Karyopharm Therapeutics Stock Prediction 2030

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Jan 2030.

In Jan 2030 analysts predict a share price of $2.37. An increase of 105.95% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Feb 2030.

In Feb 2030 analysts predict a share price of $2.41. An increase of 109.93% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Mar 2030.

In Mar 2030 analysts predict a share price of $2.46. An increase of 113.91% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Apr 2030.

In Apr 2030 analysts predict a share price of $2.51. An increase of 117.88% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in May 2030.

In May 2030 analysts predict a share price of $2.55. An increase of 121.86% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Jun 2030.

In Jun 2030 analysts predict a share price of $2.60. An increase of 125.84% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Jul 2030.

In Jul 2030 analysts predict a share price of $2.64. An increase of 129.82% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Aug 2030.

In Aug 2030 analysts predict a share price of $2.69. An increase of 133.79% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Sep 2030.

In Sep 2030 analysts predict a share price of $2.73. An increase of 137.77% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Oct 2030.

In Oct 2030 analysts predict a share price of $2.78. An increase of 141.75% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Nov 2030.

In Nov 2030 analysts predict a share price of $2.83. An increase of 145.73% compared to today's share price.

Stock Prediction for the Price of One Karyopharm Therapeutics Share in Dec 2030.

In Dec 2030 analysts predict a share price of $2.87. An increase of 149.7% compared to today's share price.

P/E
0.00
Beta
0.15
Price-to-book Ratio
N/A
Market Cap
0.12B
TEV
0.27 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$6.00

Karyopharm Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Karyopharm Therapeutics Inc.?

The following analysts have recently covered Karyopharm Therapeutics:

Baird
Barclays
H.C. Wainwright & Co.
Jefferies LLC
Marktfeld
RBC Capital Markets
Leerink Partners LLC
Piper Sandler Companies
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Karyopharm Therapeutics Inc.?

The following sell-side analysts have recently covered Karyopharm Therapeutics:

Kusy, Colleen Margaret
Lawson, Peter Richard
White, Edward Patrick
Raycroft, Maurice Thomas
Paraskevopoulos, Michail
Davis, Luke
Chang, Wei Ji
Raymond, Christopher Joseph
(This information refers to the last 90 days.)